ENFORCER
LIVE

Serial Number

88461039

Owner

MorphoSys AG

Attorney

Frances M. Jagla

Filing Date

Jun 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ENFORCER Trademark

Serial Number: 88461039 • Registration: 5981450

ENFORCER is a trademark filed by MorphoSys AG on June 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MorphoSys AG (48 trademarks)

Lena-Christ-Strasse 48
82152 Martinsried/Planegg , DE

Entity Type: 03

Incyte Holdings Corporation (151 trademarks)

Wilmington, DE 19803

Entity Type: 03

Trademark Details

Filing Date

June 5, 2019

Registration Date

February 11, 2020

Published for Opposition

November 26, 2019

Goods & Services

Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 11, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2024 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 24, 2024 ASCK
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Oct 17, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 11, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 10, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 3, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 3, 2019 GNSL
SUSPENSION LETTER WRITTEN
Sep 3, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2019 CRFA
ASSIGNED TO LIE
Aug 29, 2019 ALIE
ASSIGNED TO EXAMINER
Aug 26, 2019 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 21, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2019 NWOS
NEW APPLICATION ENTERED
Jun 8, 2019 NWAP